221 related articles for article (PubMed ID: 38535786)
1. Apitoxin and Its Components against Cancer, Neurodegeneration and Rheumatoid Arthritis: Limitations and Possibilities.
Aufschnaiter A; Kohler V; Khalifa S; Abd El-Wahed A; Du M; El-Seedi H; Büttner S
Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 31973181
[TBL] [Abstract][Full Text] [Related]
2. Bee Venom-Loaded Niosomes as Innovative Platforms for Cancer Treatment: Development and Therapeutical Efficacy and Safety Evaluation.
Pinto MB; Pires PC; Calhelha RC; Silva AR; Sousa MJ; Vilas-Boas M; Falcão SI; Veiga F; Makvandi P; Paiva-Santos AC
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794142
[TBL] [Abstract][Full Text] [Related]
3. Bee Venom: Composition and Anticancer Properties.
Gajski G; Leonova E; Sjakste N
Toxins (Basel); 2024 Feb; 16(3):. PubMed ID: 38535786
[TBL] [Abstract][Full Text] [Related]
4. The Cytotoxic Effect of
Yaacoub C; Rifi M; El-Obeid D; Mawlawi H; Sabatier JM; Coutard B; Fajloun Z
Molecules; 2021 Apr; 26(8):. PubMed ID: 33919706
[TBL] [Abstract][Full Text] [Related]
5. Bee Venom Components as Therapeutic Tools against Prostate Cancer.
Badawi JK
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34067049
[TBL] [Abstract][Full Text] [Related]
6. Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line.
Obeidat M; Al-Khraisat IF; Jaradat DMM; Ghanim BY; Abdallah QM; Arqoub DA; Sabbah D; Al-Sanabra OM; Arafat T; Qinna NA
BMC Complement Med Ther; 2023 Apr; 23(1):132. PubMed ID: 37098530
[TBL] [Abstract][Full Text] [Related]
7. An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers.
Pandey P; Khan F; Khan MA; Kumar R; Upadhyay TK
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513529
[TBL] [Abstract][Full Text] [Related]
8. Bee venom in cancer therapy.
Oršolić N
Cancer Metastasis Rev; 2012 Jun; 31(1-2):173-94. PubMed ID: 22109081
[TBL] [Abstract][Full Text] [Related]
9. Polypeptides from traditional Chinese medicine: Comprehensive review of perspective towards cancer management.
Jia Z; Zhu X; Zhou Y; Wu J; Cao M; Hu C; Yu L; Xu R; Chen Z
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129423. PubMed ID: 38232868
[TBL] [Abstract][Full Text] [Related]
10. Investigation the effects of bee venom and H-dental-derived mesenchymal stem cells on non-small cell lung cancer cells (A549).
Sengul F; Vatansev H; Ozturk B
Mol Biol Rep; 2023 Dec; 51(1):2. PubMed ID: 38057592
[TBL] [Abstract][Full Text] [Related]
11. Melittin kills A549 cells by targeting mitochondria and blocking mitophagy flux.
Li X; Li Z; Meng YQ; Qiao H; Zhai KR; Li ZQ; Wei SL; Li B
Redox Rep; 2023 Dec; 28(1):2284517. PubMed ID: 38041592
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered nano-melittin vesicles for multimodal synergetic cancer therapy.
Zhang J; Liu X; Xia Y; Xu S; Liu X; Xiao H; Wang X; Liu C; Liu G
Bioeng Transl Med; 2023 Nov; 8(6):e10482. PubMed ID: 38023709
[TBL] [Abstract][Full Text] [Related]
13. Cationic Proteins Rich in Lysine Residue Trigger Formation of Non-bilayer Lipid Phases in Model and Biological Membranes: Biophysical Methods of Study.
Li M; Gasanoff ES
J Membr Biol; 2023 Dec; 256(4-6):373-391. PubMed ID: 37735238
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
